E-LIB Suche - Ergebnisse für: Leger, Gabriel

1

Multisite ALLFTD study modeling progressive empathy loss fr..:

Toller, Gianina ; Cobigo, Yann ; Callahan, Patrick...
Alzheimer's & Dementia. 19 (2023) 7 - p. 2842-2852 , 2023

Link: https://doi.org/10.1002/..

2

A Phase 2a proof‐of‐concept double‐blind, randomized, place..:

Grill, Joshua D. ; Tam, Steven ; Thai, Gaby...
Alzheimer's & Dementia. 19 (2023) S21 - p. , 2023

Link: https://doi.org/10.1002/..

3

IC‐P‐007: Use of multimodal imaging in uncovering the patho..:

Chertkow, Howard ; Nikelski, James ; Leger, Gabriel...
Alzheimer's & Dementia. 8 (2012) 4S_Part_1 - p. , 2012

Link: https://doi.org/10.1016/..

4

P3‐105: Use of multi‐modal imaging in uncovering the pathol..:

Chertkow, Howard ; Nikelski, James ; Leger, Gabriel...
Alzheimer's & Dementia. 8 (2012) 4S_Part_13 - p. , 2012

Link: https://doi.org/10.1016/..

5

P2‐093: Differentiating Alzheimer's disease from FTD: Do PI..:

Chertkow, Howard ; Nikelski, James ; Nasreddine, Ziad.
Alzheimer's & Dementia. 7 (2011) 4S_Part_10 - p. , 2011

Link: https://doi.org/10.1016/..

6

P2‐094: Correlating imaging with language impairment in deg..:

Chertkow, Howard ; Nikelski, James ; Léger, Gabriel...
Alzheimer's & Dementia. 7 (2011) 4S_Part_10 - p. , 2011

Link: https://doi.org/10.1016/..

7

Toward a revision of criteria for the dementias:

Rockwood, Kenneth ; Bouchard, Rémi W. ; Camicioli, Richard.
Alzheimer's & Dementia. 3 (2007) 4 - p. 428-440 , 2007

Link: https://doi.org/10.1016/..

8

3‐O‐methyldopa administration does not alter fluorodopa tra..:

Guttman, Mark ; Léger, Gabriel ; Cedarbaum, Jesse M....
Annals of Neurology. 31 (1992) 6 - p. 638-643 , 1992

Link: https://doi.org/10.1002/..

9

Dopa Decarboxylase Activity of the Living Human Brain:

Gjedde, Albert ; Reith, Jakob ; Dyve, Suzan...
Proceedings of the National Academy of Sciences of the United States of America. 88 (1991) 7 - p. 2721-2725 , 1991

Link: https://www.jstor.org/st..

10

Reduction of Circulating 3-O-Methyldopa by Inhibition of Ga..:

Cedarbaum, Jesse M. ; Leger, Gabriel ; Guttman, Mark
Clinical Neuropharmacology. 14 (1991) 4 - p. 330-342 , 1991

Link: https://doi.org/10.1097/..

11

Effect of Nitecapone (OR-462) on the Pharmacokinetics of Le..:

Cedarbaum, Jesse M. ; Léger, Gabriel ; Reches, Avinoam.
Clinical Neuropharmacology. 13 (1990) 6 - p. 544-552 , 1990

Link: https://doi.org/10.1097/..

12

Synthesis and biomethylenation of two homoallylically fluor..:

Buist, Peter H. ; Findlay, Judy M. ; Léger, Gabriel.
Tetrahedron Letters. 28 (1987) 34 - p. 3891-3894 , 1987

Link: https://doi.org/10.1016/..

13

Protocol for a seamless phase 2A-phase 2B randomized double..:

Feldman, Howard H. ; Luchsinger, José A. ; Léger, Gabriel C....
PLOS ONE. 19 (2024) 5 - p. e0302998 , 2024

Link: https://doi.org/10.1371/..

14

Prognostic value of plasma biomarkers in a clinical trial o..:

Qiu, Yuqi ; Messer, Karen ; Jacobs, Diane M....
Alzheimer's & Dementia. 19 (2023) S15 - p. , 2023

Link: https://doi.org/10.1002/..

15

Case report: Neuronal intranuclear inclusion disease presen..:

Bu, Julia Ting ; Torres, Dolores ; Robinson, Adam...
Frontiers in Neurology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..